RA0461

antibody from Oursmab

Targeting: LGALS3 GALIG, LGALS2, MAC-2

Western blot (Supportive data in Antibodypedia)

ELISA (Recommended by provider)

Immunocytochemistry (Recommended by provider)

Flow cytometry (Recommended by provider)

Functional assay (Recommended by provider)

Antibody Data

Product number

RA0461

Provider

Oursmab

Product name

Oloctinebart (Biosimilar Reference Antibody) (LGALS3)

Antibody type

Monoclonal

Description

Oloctinebart is a humanized monoclonal antibody that specifically targets galectin-3 (Gal-3, encoded by the LGALS3 gene), a ¦Â-galactoside-binding lectin involved in multiple pathological processes. By binding to galectin-3, oloctinebart blocks its interaction with ligands, thereby inhibiting its pleiotropic functions in inflammation, fibrosis, immune modulation, and tumor progression. It is being developed as a potential therapeutic for galectin-3-driven diseases, including fibrotic disorders (e.g., non-alcoholic steatohepatitis, pulmonary fibrosis), certain cancers, and chronic inflammatory conditions.

Reactivity

Human

Isotype

IgG

Vial size

100 ¦Ìg,1 mg,5 mg,10 mg,25 mg,50 mg,100 mg

Concentration

Bottled at the concentration indicated on the vial.

Storage

Store at -20¡ãC or -80¡ãC. Avoid repeated freeze.

Western blot

Supportive validation

Submitted by

Oursmab (provider)

Main image

Experimental details

Oloctinebart (Biosimilar Reference Antibody) (LGALS3)-RA0461-Oursmab determined by SDS-PAGE. The purity of the protein is greater than 98%.